医药产业链数据库之：零售药房经营数据，2025年3月实体药店销售环比有所增长

Investment Rating - The industry investment rating is "Outperform the Market - A" [10] Core Insights - The retail pharmacy industry is experiencing a recovery in sales, with a 2.97% month-on-month increase in average daily sales per store in March 2025 [4][17] - The structure of listed pharmacy stores is gradually optimizing, which is expected to lead to stable performance growth for several companies [5][29] - The market size of domestic retail pharmacies decreased by 1.77% year-on-year in 2024, reaching 611.9 billion yuan [14] Summary by Sections Macro Perspective - In March 2025, the average daily sales per store in retail pharmacies showed a month-on-month increase, with average sales of 3,020.1 yuan [4][17] - The average daily sales for January to March 2025 were 2,973.8 yuan, 2,933.1 yuan, and 3,020.1 yuan respectively [17] Micro Perspective - The retail pharmacy industry has seen a slowdown in growth, but the concentration of the industry is expected to increase significantly. The market share of the top six listed pharmacies was only 16.89% in 2023 [23] - The revenue growth rates for the retail pharmacy industry and the top six listed pharmacies in 2023 were 1.83% and 11.83% respectively [23] - The proportion of new stores (2-3 years old) for major listed pharmacies in Q1-Q3 2024 was as follows: Yifeng Pharmacy 30%, Dazhenglin 25%, Laobaixing 30%, Yixintang 15%, Jianzhijia 38%, and Shuyupingmin 34% [5][29]